22h agoInvesting.com MarketsBULLISH 55General
Why is AnaptysBio stock rising afterhours today?
Why is AnaptysBio stock rising afterhours today?
Archived explainer. For the current picture see today's ANAB page.
Why Is ANAPTYSBIO INC (ANAB) Stock Down Today?
By the Top Tier Newswire AI Desk · September 22, 2026 at 12:28 PM ET · reviewed against 4 wire stories
ANAPTYSBIO INC (ANAB) is down -6.12% in the latest session. Our newswire has captured 4 stories on ANAB across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 59/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why ANAB stock is down today
AnaptysBio Inc (ANAB) fell 6.12% to $51.56 on Friday, marking a sharp reversal from its morning high. The stock opened with a 2.0% gap up but quickly reversed course as traders reacted to mixed signals from the company’s recent earnings report and broader market sentiment.
What Happened
AnaptysBio reported Q2 GAAP earnings of $5.11 per share, a significant improvement from a loss of $1.30 per share in the same period last year. The company also generated $27.5 million in revenue, up 23.5% year-over-year and $7.38 million above expectations. However, despite these positive figures, the stock declined sharply during the session. The company filed a Form 8-K with the SEC on September 21, 2026, disclosing its financial results and related documents. The filing included details of the company’s cash, cash equivalents, and investments, but did not include new product or partnership announcements that might have driven sustained optimism.
Retail traders and analysts have been divided in recent days. TD Cowen and HC Wainwright & Co. both maintain Buy ratings on ANAB, with price targets of $70 and $95, respectively. However, the stock’s performance on Friday suggests that investors are reassessing the valuation amid a broader market pullback and a lack of new catalysts.
What The Data Shows
The stock opened at $56.02, a 2.0% gap up from the prior close, but fell to a session low of $50.61 by midday. Volume was 0.2 million shares, or 0.4 times the 3-month daily average, indicating moderate participation. ANAB has a market cap of $1.6 billion and a beta of 0.41, suggesting it is less volatile than the broader market. The stock has traded between $20.49 and $73.30 over the past 52 weeks and is currently down 30.6% from its 52-week high. The company remains unprofitable with a trailing twelve-month net margin of -11.5% and an EPS of -0.95.
What To Watch
The stock is scheduled to report no upcoming earnings. Investors should monitor coverage breadth and analyst commentary for any shifts in sentiment ahead of the next earnings cycle.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
ANAB by the numbers
Last: $51.56Session: -6.12%Coverage: 4 stories / 4 sourcesAI sentiment: 59/100 (bullish)Mkt cap: $1.6B52w: $20.49 to $73.30
The headlines behind the move
1d agoThe FlyBULLISH 63Earnings
AnaptysBio reports Q2 diluted EPS $5.11 vs. ($1.30) last year
1d agoSeeking AlphaBULLISH 68Earnings
AnaptysBio GAAP EPS of $5.11 beats by $5.02, revenue of $27.5M beats by $7.38M
AnaptysBio press release (ANAB): Q2 GAAP EPS of $5.11 beats by $5.02. Revenue of $27.5M (+23.5% Y/Y) beats by $7.38M. Cash, cash equivalents and investments tot
1d agoSEC 8-KNEUTRAL 50General
ANAPTYSBIO, INC (ANAB) files 8-K
Filed: 2026-09-21 AccNo: 0001193125-26-396690 Size: 531 KB Item 9.01: Financial Statements and Exhibits
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on ANAB: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier ANAB move explainers: 2026-09-22